Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Xyphos Biosciences
Xyphos Biosciences
Astellas-owned Xyphos offers more than $800M for Kelonia's in vivo delivery know-how
Fierce Biotech
Thu, 02/15/24 - 07:21 pm
Xyphos Biosciences
Astellas
Kelonia
R&D
Corporate and regulatory developments over the Christmas period
EP Vantage
Thu, 01/2/20 - 11:39 pm
Astellas
M&A
Qiagen
AstraZeneca
Bausch Health
BeiGene
Celyad
Immunomedics
Merck
Merck KGaA
Ono Pharmaceutical
Pfizer
Pharming
Xyphos Biosciences
Astellas ramps up M&A, buys U.S. biotech Xyphos for as much as $665 million
Reuters
Mon, 12/30/19 - 10:59 am
Astellas
Xyphos Biosciences
M&A
Audentes Therapeutics
Parker Institute backs an upstart biotech looking to develop a new, convertible CAR-T
Endpoints
Thu, 10/18/18 - 11:27 pm
CAR-T
Xyphos Biosciences